| 06/08/2026 4:19 PM | BiomX (1739174) Filer | Form DEF 14A | |
| 06/05/2026 3:30 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2026 5:13 PM | BiomX (1739174) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13D/A | |
| 05/28/2026 7:09 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:52 PM | BiomX (1739174) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/14/2026 6:39 PM | BiomX (1739174) Subject Centaurus Investments Ltd (1993498) Filed by | Form SCHEDULE 13G/A | |
| 05/05/2026 3:21 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 4:05 PM | BiomX (1739174) Filer | Form 10-K/A | |
| 04/16/2026 4:11 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 4:37 PM | BiomX (1739174) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13D/A | |
| 04/14/2026 7:00 AM | BiomX (1739174) Subject T3 Defense Inc. (1787518) Filed by T3 Defense Inc. (1787518) Filed by | Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for PHGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/13/2026 8:23 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/10/2026 4:15 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/10/2026 4:16 PM | BiomX (1739174) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 04/10/2026 2:40 PM | BiomX (1739174) Subject T3 Defense Inc. (1787518) Filed by T3 Defense Inc. (1787518) Filed by | Form SCHEDULE 13D | |
| 04/10/2026 7:47 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 8:47 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 3:50 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 6:06 PM | BiomX (1739174) Filer | Form DEF 14A | |
| 03/19/2026 8:25 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/18/2026 4:47 PM | BiomX (1739174) Issuer Yeganeh Reuven (2044677) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/11/2026 3:24 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/06/2026 7:54 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/03/2026 8:27 PM | Bidas Liat Cohavi (2115651) Reporting BiomX (1739174) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/19/2026 10:16 AM | BiomX (1739174) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/17/2026 3:47 PM | Alyeska Investment Group, L.P. (1453072) Filed by BiomX (1739174) Subject | Form SCHEDULE 13G/A | |
| 02/16/2026 11:15 PM | BiomX (1739174) Filer | Form EFFECT | |
| 02/11/2026 6:24 PM | BiomX (1739174) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13D/A | |
| 01/29/2026 7:33 PM | BiomX (1739174) Subject HIRSCHMAN ORIN (1131362) Filed by | Form SCHEDULE 13G/A | |
| 01/26/2026 3:05 PM | BiomX (1739174) Subject Yeganeh Reuven (2044677) Filed by | Form SCHEDULE 13D | |
| 01/20/2026 3:01 PM | BiomX (1739174) Filer | Form D Notice of Exempt Offering of Securities | |
| 01/16/2026 6:59 PM | BiomX (1739174) Issuer Yeganeh Reuven (2044677) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 3:05 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 3:05 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/29/2025 4:29 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/08/2025 7:05 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/25/2025 4:00 PM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/17/2025 6:56 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 6:45 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 9:02 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 8:57 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history.
But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing |
| 08/28/2025 4:14 PM | BiomX (1739174) Filer | Form ARS | |
| 08/28/2025 3:46 PM | BiomX (1739174) Filer | Form DEF 14A | |
| 08/19/2025 8:22 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 8:12 AM | BiomX (1739174) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/13/2025 6:24 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/30/2025 9:02 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/08/2025 8:15 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/23/2025 4:08 PM | BiomX (1739174) Subject OrbiMed Israel BioFund GP Limited Partnership (1569821) Filed by | Form SCHEDULE 13D/A | |
| 06/09/2025 8:23 AM | BiomX (1739174) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |